Bifogade filer
Kurs & Likviditet
Kalender
2024-11-14 | Kvartalsrapport 2024-Q3 |
2024-08-23 | Kvartalsrapport 2024-Q2 |
2024-05-03 | Kvartalsrapport 2024-Q1 |
2024-03-15 | Ordinarie utdelning ALK B 0.00 DKK |
2024-03-14 | Årsstämma 2024 |
2024-02-08 | Bokslutskommuniké 2023 |
2023-11-15 | Kvartalsrapport 2023-Q3 |
2023-08-24 | Kvartalsrapport 2023-Q2 |
2023-05-09 | Kvartalsrapport 2023-Q1 |
2023-03-20 | Ordinarie utdelning ALK B 0.00 DKK |
2023-02-03 | Bokslutskommuniké 2022 |
2022-11-10 | Kvartalsrapport 2022-Q3 |
2022-08-11 | Kvartalsrapport 2022-Q2 |
2022-05-12 | Kvartalsrapport 2022-Q1 |
2022-03-28 | Split ALK B 1:20 |
2022-03-17 | Ordinarie utdelning ALK B 0.00 DKK |
2022-03-16 | Årsstämma 2022 |
2022-02-08 | Bokslutskommuniké 2021 |
2021-11-11 | Kvartalsrapport 2021-Q3 |
2021-08-11 | Kvartalsrapport 2021-Q2 |
2021-05-05 | Kvartalsrapport 2021-Q1 |
2021-03-19 | Ordinarie utdelning ALK B 0.00 DKK |
2021-03-18 | Årsstämma 2021 |
2021-02-10 | Bokslutskommuniké 2020 |
2020-11-11 | Kvartalsrapport 2020-Q3 |
2020-08-12 | Kvartalsrapport 2020-Q2 |
2020-05-06 | Kvartalsrapport 2020-Q1 |
2020-03-12 | Ordinarie utdelning ALK B 0.00 DKK |
2020-03-11 | Årsstämma 2020 |
2020-02-05 | Bokslutskommuniké 2019 |
2019-11-07 | Kvartalsrapport 2019-Q3 |
2019-08-13 | Kvartalsrapport 2019-Q2 |
2019-05-09 | Kvartalsrapport 2019-Q1 |
2019-03-14 | Ordinarie utdelning ALK B 0.00 DKK |
2019-03-13 | Årsstämma 2019 |
2019-02-07 | Bokslutskommuniké 2018 |
2018-11-09 | Kvartalsrapport 2018-Q3 |
2018-08-15 | Kvartalsrapport 2018-Q2 |
2018-05-04 | Kvartalsrapport 2018-Q1 |
2018-03-13 | Ordinarie utdelning ALK B 0.00 DKK |
2018-03-12 | Årsstämma 2018 |
2018-02-06 | Bokslutskommuniké 2017 |
2017-11-10 | Kvartalsrapport 2017-Q3 |
2017-08-16 | Kvartalsrapport 2017-Q2 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-03-16 | Ordinarie utdelning ALK B 5.00 DKK |
2017-03-15 | Årsstämma 2017 |
2017-02-07 | Bokslutskommuniké 2016 |
2016-11-10 | Kvartalsrapport 2016-Q3 |
2016-08-16 | Kvartalsrapport 2016-Q2 |
2016-05-04 | Kvartalsrapport 2016-Q1 |
2016-03-11 | Ordinarie utdelning ALK B 5.00 DKK |
2016-03-10 | Årsstämma 2016 |
2016-02-09 | Bokslutskommuniké 2015 |
2015-11-12 | Kvartalsrapport 2015-Q3 |
2015-08-18 | Kvartalsrapport 2015-Q2 |
2015-05-05 | Kvartalsrapport 2015-Q1 |
2015-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
2015-03-12 | Årsstämma 2015 |
2015-02-09 | Bokslutskommuniké 2014 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-05-08 | Kvartalsrapport 2014-Q1 |
2014-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
2014-03-12 | Årsstämma 2014 |
2014-02-05 | Bokslutskommuniké 2013 |
2013-11-08 | Kvartalsrapport 2013-Q3 |
2013-08-14 | Kvartalsrapport 2013-Q2 |
2013-05-03 | Kvartalsrapport 2013-Q1 |
2013-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
2013-03-12 | Årsstämma 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-11-12 | Kvartalsrapport 2012-Q3 |
2012-08-16 | Kvartalsrapport 2012-Q2 |
2012-05-10 | Kvartalsrapport 2012-Q1 |
2012-03-28 | Ordinarie utdelning ALK B 5.00 DKK |
2012-03-27 | Årsstämma 2012 |
2012-02-22 | Bokslutskommuniké 2011 |
2011-11-11 | Kvartalsrapport 2011-Q3 |
2011-08-16 | Kvartalsrapport 2011-Q2 |
2011-05-10 | Kvartalsrapport 2011-Q1 |
2011-04-04 | Ordinarie utdelning ALK B 5.00 DKK |
2011-04-01 | Årsstämma 2011 |
2010-03-29 | Ordinarie utdelning ALK B 5.00 DKK |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
ALK-Abelló A/S (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has completed a share split at a ratio of 1:20 with registration of new ISIN code and face value (nominal denomination) of the company’s B shares registered with VP Securities A/S (Euronext) on 29 March 2022.
In accordance with section 32 of the Danish Capital Markets Act, ALK-Abelló A/S is required to disclose the total number of voting rights and share capital no later than by the end of the calendar month in which the share split has taken place.
Following the share split, the company’s share capital remains DKK 111,411,960 divided into DKK 9,207,600 A shares, DKK 920,760 AA shares and DKK 101,283,600 B shares. The share split implies that the share capital is divided into 18,415,200 A shares, 1,841,520 AA shares and 202,567,200 B shares, each having a nominal value of DKK 0.50. Upon completion of the share split, each A share and AA share of a nominal value of DKK 0.50 shall have 10 votes and each B share of a nominal value of DKK 0.50 shall have one vote.
ALK-Abelló A/S
For further information, please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,600 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.